School of Medicine, Southeast University, Nanjing, 210009, Jiangsu, China.
Department of Surgery, TUM School of Medicine, Klinikum rechts der Isar, Technical University of Munich, 81675, Munich, Germany.
Epigenetics Chromatin. 2024 Feb 17;17(1):4. doi: 10.1186/s13072-024-00531-z.
In the past decade, numerous epigenetic mechanisms have been discovered to be associated with cancer. The mammalian SWI/SNF complex is an ATP-dependent chromatin remodeling complex whose mutations are associated with various malignancies including breast cancer. As the SWI/SNF complex has become one of the most commonly mutated complexes in cancer, targeting epigenetic mutations acquired during breast cancer progress is a potential means of improving clinical efficacy in treatment strategies. This article reviews the composition of the SWI/SNF complex, its main roles and research progress in breast cancer, and links these findings to the latest discoveries in cancer epigenomics to discuss the potential mechanisms and therapeutic potential of SWI/SNF in breast cancer.
在过去的十年中,人们发现了许多与癌症相关的表观遗传机制。哺乳动物 SWI/SNF 复合物是一种依赖于 ATP 的染色质重塑复合物,其突变与多种恶性肿瘤有关,包括乳腺癌。由于 SWI/SNF 复合物已成为癌症中最常发生突变的复合物之一,针对乳腺癌进展过程中获得的表观遗传突变是提高治疗策略临床疗效的一种潜在手段。本文综述了 SWI/SNF 复合物的组成、在乳腺癌中的主要作用和研究进展,并将这些发现与癌症表观基因组学的最新发现联系起来,讨论了 SWI/SNF 在乳腺癌中的潜在机制和治疗潜力。